Johns Hopkins Researchers Aim to Clarify mRNA Vaccine Misconceptions

Experts discuss the benefits of mRNA technology and its potential future applications beyond COVID-19.

Mar. 27, 2026 at 2:02am

Researchers at the Johns Hopkins Bloomberg School of Public Health are seeking to address misconceptions around mRNA vaccines, which gained prominence during the COVID-19 pandemic. They highlight the speed and flexibility of mRNA technology, which could lead to more effective flu vaccines and personalized cancer treatments. The experts also refute claims that mRNA vaccines cause fertility issues in women.

Why it matters

As mRNA vaccines continue to be a topic of debate, these researchers aim to provide clarity and dispel myths around the technology. Understanding the benefits and potential of mRNA could help drive further advancements in public health and medicine.

The details

mRNA vaccines use synthetic molecules rather than live viruses, teaching the body's immune cells to produce antigens to fight disease. This allows the vaccines to be produced much faster than traditional methods. Experts say mRNA technology could revolutionize flu vaccines, allowing for more accurate and effective shots each season. Researchers are also exploring the use of mRNA for personalized cancer treatments, as the quick production time enables tailored therapies. Recent studies have shown mRNA vaccines do not cause fertility problems in women.

  • The mRNA vaccines gained attention during the height of the COVID-19 pandemic.
  • Flu vaccine predictions are typically made in February for the upcoming September season.

The players

Dr. Andrew Pekosz

Professor at the Johns Hopkins Bloomberg School of Public Health.

Dr. Gigi Gronvall

Senior scholar at the Johns Hopkins Center for Health Security.

Got photos? Submit your photos here. ›

What they’re saying

“It's sort of like switching from a horse and buggy to a Corvette for travel. The mRNA still does the basic thing, just a lot faster.”

— Dr. Andrew Pekosz, Professor

“mRNA vaccines can make flu vaccines more effective than (they are) currently, and better matched against the viruses that we're all likely to be exposed to in the flu season.”

— Dr. Gigi Gronvall, Senior scholar

What’s next

Researchers are continuing to explore the potential of mRNA technology for a variety of applications, including more effective flu vaccines and personalized cancer treatments.

The takeaway

While mRNA vaccines gained prominence during the COVID-19 pandemic, this technology holds promise for the future of public health and medicine. By addressing misconceptions, experts hope to drive further advancements and unlock the full potential of this innovative approach.